Patent · US Active

Targeted engineered interferon and uses thereof

US10906985B2 · kind B2 · utility

4Cited by

15References

16Claims

0Family size

Assignee

Orionis Biosciences, Inc · US

Inventors

Nikolai KLEY · Waltham, US
Lennart ZABEAU · Evergem, BE
Jan Tavernier · Balegem, BE

Key dates

Filing date	Feb 5, 2018
Grant date	Feb 2, 2021
Priority date	—
Expiry date	Feb 5, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/33
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates, in part, to chimeric proteins comprising consensus interferon, or a variant thereof, and their use as therapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.